NO20015600L - Anvendelse av 1,4-benzotiazepin-derivater som legemidler for å overvinne resistens mot anticancer legemidler - Google Patents

Anvendelse av 1,4-benzotiazepin-derivater som legemidler for å overvinne resistens mot anticancer legemidler

Info

Publication number
NO20015600L
NO20015600L NO20015600A NO20015600A NO20015600L NO 20015600 L NO20015600 L NO 20015600L NO 20015600 A NO20015600 A NO 20015600A NO 20015600 A NO20015600 A NO 20015600A NO 20015600 L NO20015600 L NO 20015600L
Authority
NO
Norway
Prior art keywords
drugs
anticancer
anticancer drugs
resistance
overcoming
Prior art date
Application number
NO20015600A
Other languages
English (en)
Norwegian (no)
Other versions
NO20015600D0 (no
Inventor
Noboru Kaneko
Kazuhito Nishio
Takashi Nakamura
Original Assignee
Noboru Kaneko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noboru Kaneko filed Critical Noboru Kaneko
Publication of NO20015600D0 publication Critical patent/NO20015600D0/no
Publication of NO20015600L publication Critical patent/NO20015600L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20015600A 1999-05-19 2001-11-16 Anvendelse av 1,4-benzotiazepin-derivater som legemidler for å overvinne resistens mot anticancer legemidler NO20015600L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13919699 1999-05-19
PCT/JP2000/003216 WO2000071132A1 (fr) 1999-05-19 2000-05-19 Utilisation de derives 1,4-benzothiazepine en tant que medicaments contre la tolerance cancerostatique

Publications (2)

Publication Number Publication Date
NO20015600D0 NO20015600D0 (no) 2001-11-16
NO20015600L true NO20015600L (no) 2001-12-20

Family

ID=15239803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015600A NO20015600L (no) 1999-05-19 2001-11-16 Anvendelse av 1,4-benzotiazepin-derivater som legemidler for å overvinne resistens mot anticancer legemidler

Country Status (12)

Country Link
US (1) US6977252B1 (ko)
EP (1) EP1184037B1 (ko)
KR (1) KR100686617B1 (ko)
CN (1) CN1178663C (ko)
AT (1) ATE298575T1 (ko)
AU (1) AU774656B2 (ko)
CA (1) CA2373484C (ko)
DE (1) DE60021075T2 (ko)
NO (1) NO20015600L (ko)
TW (1) TWI221093B (ko)
WO (1) WO2000071132A1 (ko)
ZA (1) ZA200109334B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7718644B2 (en) 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US7879840B2 (en) 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
CN1311818C (zh) * 2004-11-22 2007-04-25 山东蓝金生物工程有限公司 一种抗实体肿瘤的药物组合物
US7704990B2 (en) 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US8835506B2 (en) 2008-06-05 2014-09-16 Stc.Unm Methods and related compositions for the treatment of cancer
AU2015297705B2 (en) 2014-07-30 2019-12-19 Aetas Pharma Co., Ltd. Optical isomer of 1,4-benzothiazepine-1-oxide derivative, and pharmaceutical composition prepared using same
KR102440098B1 (ko) * 2020-07-31 2022-09-05 부산대학교 산학협력단 Agr2의 동종이량체를 표적으로 하는 저분자 화합물을 유효성분으로 함유하는 암 예방 또는 치료용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS579712A (en) * 1980-06-20 1982-01-19 Fukumi Morishige Instilling (dripping) liquid for intravenous injection
JP2703408B2 (ja) 1990-12-28 1998-01-26 麒麟麦酒株式会社 １，４‐ベンゾチアゼピン誘導体
JP3093419B2 (ja) * 1992-03-30 2000-10-03 麒麟麦酒株式会社 １，４‐ベンゾチアゼピン誘導体
US5643909A (en) 1993-04-19 1997-07-01 Syntex (U.S.A.) Inc. 10,11-Methanodibenzosuberane derivatives
US5700826A (en) 1995-06-07 1997-12-23 Ontogen Corporation 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance
JP4063964B2 (ja) * 1998-08-12 2008-03-19 金子 昇 神経細胞保護薬

Also Published As

Publication number Publication date
EP1184037B1 (en) 2005-06-29
CA2373484A1 (en) 2000-11-30
CN1361693A (zh) 2002-07-31
WO2000071132A1 (fr) 2000-11-30
CN1178663C (zh) 2004-12-08
TWI221093B (en) 2004-09-21
EP1184037A1 (en) 2002-03-06
US6977252B1 (en) 2005-12-20
DE60021075T2 (de) 2006-05-24
CA2373484C (en) 2009-01-20
DE60021075D1 (de) 2005-08-04
AU4778300A (en) 2000-12-12
ZA200109334B (en) 2003-01-29
EP1184037A4 (en) 2003-12-03
NO20015600D0 (no) 2001-11-16
KR20020008407A (ko) 2002-01-30
ATE298575T1 (de) 2005-07-15
KR100686617B1 (ko) 2007-02-23
AU774656B2 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
NO20024424L (no) Glykopyranosyloksybenzylbenzenderivater, medisinske sammensetninger inneholdende slike, samt intermediater tilfremstilling av derivatene
DE60119894D1 (de) Piperidinverbindungen und diese enthaltenden medikamente
DE602005027213D1 (de) Neue imidazolidinderivate
NO20014925D0 (no) Farmasöytiske forbindelser
PT976748E (pt) Derivados de pirrolidina com actividade inibidora de fosfolipase a2
ATE271045T1 (de) Sauerstoffhaltige heterocyclische verbindungen
CY1111816T1 (el) Παραγωγο θειαδιαζολινης για την θεραπεια του καρκινου
DE69935718D1 (de) Antidiabetische medikamente
DK0514277T3 (da) 3-aminopyradazinderivater med virkning på centralnervesystemet
NO20015600D0 (no) Anvendelse av 1,4-benzotiazepin-derivater som legemidler for å overvinne resistens mot anticancer legemidler
NO20025035D0 (no) Oksadiazolderivater som har anticancer-effekter
ATE324362T1 (de) Neue vinylbenzolderivate
ATE223411T1 (de) 1-methylcarbapenem-derivate
DE69617909D1 (de) 2-substituierte vitamin-d3-derivate
DE69208400D1 (de) Mono- und Bis-Alkylaminoanthracycline
WO2000010543A3 (de) Arzneimittel enthaltend platinkomplexverbindungen sowie deren verwendung
EP1336608A4 (en) DIBENZOSUBERANYLPIPERAZINE DERIVATIVES AND AGENTS CONTAINING THEM DERIVATIVES FOR EXCESSING MEDICINAL RESISTANCE
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament
NO20010244L (no) Medikamenter inneholdende polyhydroksyalkylpyrazinderivater, deres fremstilling samt medikamenter inneholdende derivatene
TH48410A3 (th) สารผสมแชมพู
TH48410B (th) สารผสมแชมพู
TH35543A (th) สารประกอบเบนซอกซาซิพีน การผลิต และการใช้สารเหล่านี้

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application